Product Information
VERAPAMIL SR 240 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $2.2752 per EA under NDC 52536088401. Its NADAC has been published 76 times since Mar 12, 2025.
FDA first approved this application on May 29, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
240 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536088401
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019614FDA Approved
5/29/1990
TE Code
AB
On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 240 MG CAPSULE has been published 76 times since Mar 12, 2025, and over the history we have for it it has risen 109.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2752 per EA |
|---|---|
| All-time high | $2.7190 (Apr 15, 2026) |
| All-time low | $1.0442 (Jun 18, 2025) |
| 52-week high | $2.7190 |
| 52-week low | $1.1423 |
| Median price | $1.5397 |
| Average price | $1.6213 |
| Largest weekly change | +47.8% (Aug 19, 2026) |
| Weeks tracked | 76 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 240 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 240 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $2.2752 per EA (NDC 52536088401), effective Aug 19, 2026.
How has the price of VERAPAMIL SR 240 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 240 MG CAPSULE has risen 109.5%. It has been tracked across 76 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 240 MG CAPSULE?
Since Mar 12, 2025, the NADAC for VERAPAMIL SR 240 MG CAPSULE has ranged from a low of $1.0442 (Jun 18, 2025) to a high of $2.7190 (Apr 15, 2026), with a median of $1.5397 per EA.
Are there cheaper alternatives to VERAPAMIL SR 240 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VERAPAMIL SR 240 MG CAPSULE, is $1.5397 per EA — about 32% below VERAPAMIL SR 240 MG CAPSULE.
Who manufactures VERAPAMIL SR 240 MG CAPSULE?
VERAPAMIL SR 240 MG CAPSULE (NDC 52536088401) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.